GENE ONLINE|News &
Opinion
Blog

R&D
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
Halting C.difficile with first-in-class oral enzyme & microbiome
2018-11-27
The Pioneer of CRISPR Genome Editing ─ Jennifer A. Doudna Visits Taiwan
2018-11-25
Obituary: Arthur Jay Eisenberg (1956-2018)
2018-11-14
Pembrolizumab Upstages Topline PD-1/L1 drugs in lung cancer tussle
2018-11-06
Update on Tuberculosis containment using vaccine – Taming the disease
2018-10-26
M&A
Targeted cancer radiopharma specialist – ENDOCYTE INC.’s acquisition
2018-10-23
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Finding new pharmacological approach for neuroblastoma treatment
2018-10-16
Tracking “OFF THE SHELF” CAR-T Cell therapy & an IPO worth $100M
2018-10-15
R&D
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
Long term HIV suppression by new combination therapy
2018-10-01
Clash of three migraines medications & cost benefit for patients
2018-10-01
CRISPR mediated overexpression of cocaine hydrolyzing enzyme in mouse skin patch protects against lethal overdose
2018-09-20
1 32 33 34 35
LATEST
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
EVENT
Scroll to Top